In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), ...

Vertex Energy Inc (VTNR) stock saw a modest uptick, ending the day at $0.4 which represents a slight increase of $0.05 or 14.29% from the prior close of $0.35. The stock opened at $0.35 and touched a ...

Baird has recently initiated Vertex Inc (VERX) stock to Outperform rating, as announced on July 23, 2024, according to Finviz. Earlier, on March 1, 2024, BofA Securities had raised the stock from a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Evercore ISI analyst Liisa Bayko maintained a Buy rating on Aura Biosciences Inc (AURA – Research Report) on September 13 and set a price ...

Ginkgo Bioworks introduces a protein large language model and API, developed with Google Cloud, to streamline drug discovery ...

Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $29.9 billion by 2032, ...

Vertex Pharmaceuticals Incorporated does not currently pay a dividend. Currently, Regeneron Pharmaceuticals Inc’s price-earnings ratio is 30.5. Regeneron Pharmaceuticals Inc’s trailing 12-month ...

GroupBy Inc., a SaaS-based eCommerce search and product discovery leader, announces its upcoming webinar, "Bad Data, Big Trouble: How To Turn The Corner On Poor-Quality Product Data With The Help of ...